Fennec Pharmaceuticals is trading 6% up today at $10.72 as a rally in biotech stocks and broader risk-on sentiment drive the stock higher.
- The move extends a strong trend following a gain of more than 5% on August 4, 2026, despite a lack of new company-specific news.
- Investors are rotating into higher-beta names amid record-high U.S. indexes and favorable market conditions.